jumpincactus
Premium Member
Supporter
- 11,605
- 438
In America, Charlotte’s Web is the most well-known medicinal cannabis strain without the high, thanks to a CNN special. In Israel — where medical marijuana is legally prescribed and dispensed at pharmacies — their non-psychoactive strain is called Avidekel. Both strains were bred to be very high in CBD, one of the non-psychoactive components of marijuana. Both bred very low in THC, which causes the classic high.
KanaboSeed wants to take it one step further with patented strains for different ailments.
One of Israel’s eight licensed growers, Seach Ltd., joined with an Israeli software developer in August to breed designer cannabis strains with specific traits, reports David Shamah for Times of Israel. The joint venture, KanaboSeed, just applied for its first two “registrations” — Israeli patents — for new marijuana strains. Hearings are held and public comment requested before the applications can be approved.
KanaboSeed’s research and development manager credits BreedIT, the software developer, with valuable contributions to the process. “In addition to saving time,” said Shay Avraham Sarid. “we are also developing new varieties more cost-effectively.”
Sarid said they are able to streamline the breeding process to create more, and more specific, strains.
BreedIT CEO Dr. Oded Sagee believes that his company’s technology is vital to the medical marijuana industry. He doesn’t think current marijuana strains are providing the most medical benefit possible and feels he can do better.
“We believe that with our knowledge and background we will be able to develop new breeds that will be more effective,” Sagee said in a recent interview.
In Israel, you can patent a strain of marijuana. In America, you can’t even research one.
KanaboSeed wants to take it one step further with patented strains for different ailments.
One of Israel’s eight licensed growers, Seach Ltd., joined with an Israeli software developer in August to breed designer cannabis strains with specific traits, reports David Shamah for Times of Israel. The joint venture, KanaboSeed, just applied for its first two “registrations” — Israeli patents — for new marijuana strains. Hearings are held and public comment requested before the applications can be approved.
KanaboSeed’s research and development manager credits BreedIT, the software developer, with valuable contributions to the process. “In addition to saving time,” said Shay Avraham Sarid. “we are also developing new varieties more cost-effectively.”
Sarid said they are able to streamline the breeding process to create more, and more specific, strains.
BreedIT CEO Dr. Oded Sagee believes that his company’s technology is vital to the medical marijuana industry. He doesn’t think current marijuana strains are providing the most medical benefit possible and feels he can do better.
“We believe that with our knowledge and background we will be able to develop new breeds that will be more effective,” Sagee said in a recent interview.
In Israel, you can patent a strain of marijuana. In America, you can’t even research one.
